These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23711358)

  • 41. Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial.
    Silva-Filho AL; Pereira Fde A; de Souza SS; Loures LF; Rocha AP; Valadares CN; Carneiro MM; Tavares RL; Camargos AF
    Contraception; 2013 Apr; 87(4):409-15. PubMed ID: 23228505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The levonorgestrel intrauterine system: more than a contraceptive.
    Andersson K
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():15-22. PubMed ID: 11336429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy.
    Kadir RA; Chi C
    Contraception; 2007 Jun; 75(6 Suppl):S123-9. PubMed ID: 17531603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health status function after treatment with thermal balloon endometrial ablation and levonorgestrel intrauterine system for idiopathic menorrhagia: a randomized study.
    Tam WH; Yuen PM; Shan Ng DP; Leung PL; Lok IH; Rogers MS
    Gynecol Obstet Invest; 2006; 62(2):84-8. PubMed ID: 16612101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland.
    Backman T; Huhtala S; Tuominen J; Luoto R; Erkkola R; Blom T; Rauramo I; Koskenvuo M
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():23-6. PubMed ID: 11336430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
    Rose S; Chaudhari A; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.
    Beelen P; van den Brink MJ; Herman MC; Geomini PM; Duijnhoven RG; Bongers MY
    BMC Womens Health; 2021 Feb; 21(1):57. PubMed ID: 33563257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
    Wildemeersch D; Andrade A
    Gynecol Endocrinol; 2010 May; 26(5):383-9. PubMed ID: 20192899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The levonorgestrel intrauterine system in the management of menorrhagia.
    Barrington JW; Bowen-Simpkins P
    Br J Obstet Gynaecol; 1997 May; 104(5):614-6. PubMed ID: 9166207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis.
    Qiu J; Cheng J; Wang Q; Hua J
    Med Sci Monit; 2014 Sep; 20():1700-13. PubMed ID: 25245843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up.
    Chi C; Huq FY; Kadir RA
    Contraception; 2011 Mar; 83(3):242-7. PubMed ID: 21310286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on premenstrual symptoms in women treated for menorrhagia: secondary analysis of a randomized controlled trial.
    Leminen H; Heliövaara-Peippo S; Halmesmäki K; Teperi J; Grenman S; Kivelä A; Tuppurainen M; Paavonen J; Hurskainen R
    Acta Obstet Gynecol Scand; 2012 Mar; 91(3):318-25. PubMed ID: 22168810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M; Odlind V
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
    Heikinheimo O; Lehtovirta P; Suni J; Paavonen J
    Hum Reprod; 2006 Nov; 21(11):2857-61. PubMed ID: 16880227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levonorgestrel-releasing intrauterine system versus conventional medical therapy for heavy menstrual bleeding in the Asia-Pacific region.
    Lee BS; Ling X; Asif S; Kraemer P; Hanisch JU; Inki P
    Int J Gynaecol Obstet; 2013 Apr; 121(1):24-30. PubMed ID: 23340271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of menstrual blood loss in women with ideopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2004 Aug; 70(2):165-8. PubMed ID: 15288223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The levonorgestrel intrauterine system: the benefits of reduced bleeding.
    Cameron IT
    Eur J Contracept Reprod Health Care; 2001; 6 Suppl 1():27-32. PubMed ID: 25104512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergistic effect on the treatment of menorrhagia by endometrial biopsy followed by contemporaneous insertion of the levonorgestrel intrauterine system.
    Baron YM; Craus J; Agius RC; Brincat M
    Gynecol Endocrinol; 2012 Sep; 28(9):694-8. PubMed ID: 22304721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
    Römer T; Linsberger D
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.
    Heliövaara-Peippo S; Hurskainen R; Teperi J; Aalto AM; Grénman S; Halmesmäki K; Jokela M; Kivelä A; Tomás E; Tuppurainen M; Paavonen J
    Am J Obstet Gynecol; 2013 Dec; 209(6):535.e1-535.e14. PubMed ID: 23999423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.